Colgate-Palmolive Company (CL) Stock Forecast
CL analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.95 / 5 from 21 analysts
- Price target
- $98.10 average of analyst targets
- Upside to target
- +4.2% from the latest close
- Next earnings
- October 30, 2026 EPS estimate $0.92
- 52-week range
- $74.98 – $99.14
CL analyst ratings
21 analystsNumber of analysts at each rating.
CL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.93 | $0.89 | $0.95 | $0.91 | +1.8% | 17 |
| Current fiscal year (2026) | $3.87 | $3.83 | $4.02 | $3.69 | +4.8% | 20 |
| Next fiscal year (2027) | $4.09 | $4.00 | $4.19 | $3.87 | +5.7% | 20 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.34B | $5.29B | $5.38B | +4.0% | 13 |
| Current fiscal year (2026) | $21.40B | $21.03B | $21.51B | +5.0% | 18 |
| Next fiscal year (2027) | $22.06B | $21.67B | $22.37B | +3.1% | 18 |
CL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CL revenue: reported and forecast
CL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.92 | $0.93 | $0.93 | $0.93 | $0.93 | +0.4% | 1 up · 1 down |
| Current fiscal year (2026) | $3.82 | $3.87 | $3.88 | $3.87 | $3.87 | +1.3% | 0 up · 3 down |
| Next fiscal year (2027) | $4.06 | $4.10 | $4.11 | $4.10 | $4.09 | +0.7% | 0 up · 5 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CL beat in 12 of 12.
What analysts expect from CL
21 analysts cover Colgate-Palmolive; their consensus rating is buy (3.95 on a 1–5 scale, where 5 is a strong buy). The average price target is $98.10, 4.2% above the latest close of $94.11. Analysts expect earnings of $3.87 per share for 2026, +4.8% from a year earlier. For 2027 the average estimate is $4.09 per share on revenue of $22.1 billion. Colgate-Palmolive beat the EPS estimate in 12 of the last 12 quarters.
Related: CL income statement, CL key metrics, CL chart. See the CL stock overview for the latest quote and news.
CL forecast FAQ
What is Colgate-Palmolive's price target?
The average analyst price target for Colgate-Palmolive is $98.10, 4.2% above the latest close of $94.11.
Is Colgate-Palmolive a buy, hold or sell?
Of 21 analysts covering Colgate-Palmolive, 7 rate it a strong buy, 6 a buy, 8 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Colgate-Palmolive's EPS forecast?
Analysts forecast $3.87 per share for 2026 (range $3.83 to $4.02); for 2027 the estimate is $4.09.
What is Colgate-Palmolive's revenue forecast?
The average revenue estimate for 2026 is $21.4 billion, growth of 5.0%; for 2027 it is $22.1 billion.
When does Colgate-Palmolive report earnings?
Colgate-Palmolive is expected to report results for the quarter ending September 30, 2026 on October 30, 2026 before the market opens; the EPS estimate is $0.92.
Does Colgate-Palmolive usually beat earnings estimates?
Colgate-Palmolive reported EPS at or above the analyst estimate in 12 of the last 12 quarters.